As of Oct 21
| -0.50 / -1.20%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 47.00, with a high estimate of 55.00 and a low estimate of 46.00. The median estimate represents a +14.22% increase from the last price of 41.15.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.